crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, Xinpei Deng, Jindong Xie, Danian Dai, Jinhui Zhang, Hailin Tang, Tao Wu, Zhigang Zhou, Xiaoming Xie, Jin Wang, Jin Wang
Topics & Concepts
TrastuzumabBreast cancerMedicineAcquired resistanceCancer researchInternal medicineOncologyUbiquitinCancerBiologyGeneticsGeneFerroptosis and cancer prognosisCancer-related molecular mechanisms researchClusterin in disease pathology